| 2025-12-12 |
详情>>
股本变动：
变动后总股本14146.58万股
变动原因 ▼▲
- 原因：
- Ordinary shares offered 41,379,311 shares by the company
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.07美元,归母净利润703.70万美元,同比去年增长-90.74%
|
| 2025-08-18 |
详情>>
业绩披露：
2025年中报每股收益0.01美元,归母净利润52.00万美元,同比去年增长-99.09%
|
| 2025-05-16 |
股东大会：
将于2025-06-06召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the financial years ended December 31, 2024, December 31, 2023, and December 31, 2022.
2.Approval of the Company’s annual accounts for the financial year ended on December 31, 2024.
3.Allocation of results for the financial year ended December 31, 2024.
4.Declaration of dividends of an amount of USD 35 million to be allocated to the Interim Dividend and for the balance of USD 17.5 million to be paid in November.
5.Vote on discharge (quitus) to all the members of the Board of Directors for the proper exercise of their mandate during the financial year ended December 31, 2024.
6.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé (Luxembourg) and Price Waterhouse & Co. S.R.L. (Argentina), as auditor of the Company for a period ending on the date of the general meeting approving the annual accounts for the year ending on December 31, 2025.
7.Acknowledgement of the co-optation of certain directors and election of the following members of the Board of Directors:
(i)Mr. Ivo Sarjanovic, Mr. Oscar Alejandro León Bentancor and Mr. Andres Larriera, for a term of one (1) year each, ending on the date of the Annual General Meeting of Shareholders of the Company to be held in year 2026;
(ii)Mr. Daniel González, Mr. Christian De Prati and Mr. Kyril Robert Leonid Louis-Dreyfus, for a term of two (2) years each, ending on the date of the Annual General Meeting of Shareholders of the Company to be held in year 2027;
(iii)Mrs. Manuela Artigas, Mr. Juan José Sartori Pieyro and Mr. Mariano Bosch, for a term of three (3) years each, ending on the date of the Annual General Meeting of Shareholders of the Company to be held in year 2028.
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益0.18美元,归母净利润1807.80万美元,同比去年增长-61.85%
|
| 2025-04-25 |
详情>>
业绩披露：
2022年年报每股收益0.98美元,归母净利润1.08亿美元,同比去年增长-17.24%
|
| 2025-04-25 |
详情>>
业绩披露：
2024年年报每股收益0.90美元,归母净利润9234.00万美元,同比去年增长-59.19%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.73美元,归母净利润7597.40万美元,同比去年增长-47.15%
|
| 2024-11-13 |
财报披露：
美东时间 2024-11-13 盘后发布财报
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益0.55美元,归母净利润5691.30万美元,同比去年增长-16.1%
|
| 2024-05-16 |
详情>>
业绩披露：
2024年一季报每股收益0.45美元,归母净利润4738.70万美元,同比去年增长119.70%
|
| 2024-04-26 |
详情>>
业绩披露：
2023年年报每股收益2.11美元,归母净利润2.26亿美元,同比去年增长109.26%
|
| 2024-04-08 |
股东大会：
将于2024-04-17召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the financial years ended December 31, 2023, 2022, and 2021.
2.Approval of the Company’s annual accounts for the financial year ended on December 31, 2023.
3.Allocation of results for the financial year ended on December 31, 2023.
4.Distribution of dividends payable in two installments as determined by the Board of Directors.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the financial year ended on December 31, 2023.
6.Approval of compensation of members of the Board of Directors for year 2023.
7.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31, 2024.
8.Election or as relevant re-election of the following members of the Board of Directors: (i) Mr. Guillaume van der Linden, Mr. Ivo Sarjanovic and Mrs. Manuela Vaz Artigas, for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2027.
9.Approval of compensation of members of the Board of Directors for year 2024.
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.34美元,归母净利润1.44亿美元,同比去年增长37.04%
|
| 2023-04-04 |
股东大会：
将于2023-04-19召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31, 2022, 2021, and 2020.
2.Approval of the Company’s annual accounts as of December 31, 2022.
3.Allocation of results for the year ended December 31, 2022.
4.Distribution of dividends payable in two installments as determined by the Board of Directors.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31, 2022.
6.Approval of compensation of members of the Board of Directors for year 2022.
7.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31, 2023.
8.Election of the following members of the Board of Directors: (i) Mr. Plínio Musetti, Mr. Mariano Bosch and Mr. Daniel González, for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2026.
9.Approval of compensation of members of the Board of Directors for year 2023.
|
| 2022-04-12 |
股东大会：
将于2022-04-20召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31, 2021, 2020, and 2019.
2.Approval of the Company’s annual accounts as of December 31, 2021.
3.Allocation of results for the year ended December 31, 2021.
4.Distribution of dividends payable in two installments as determined by the Board of Directors.
5.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31, 2021.
6. Approval of compensation of members of the Board of Directors for year 2021.
7.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31, 2022.
8.Election of the following members of the Board of Directors: (i) Mr. Alan L. Boyce, Mr. Andrés Velasco and Mrs. Ana Cristina Russo, for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2025.
9.Approval of compensation of members of the Board of Directors for year 2022.
10.Authorization under article 430-15 of the Luxembourg law of August 10, 1915, granted to the Company, and/or any wholly-owned subsidiary (and/or any person acting on their behalf), to from time to time and for a period of five (5) years purchase, acquire, or receive shares in the Company up to ten per cent (10%) of the issued share capital, on such terms as referred to below, and as shall further be determined by the Board of Directors of the Company; whereby any shares held in treasury further to such authorization being able to held for a period of five (5) years.
11.Reduction of the issued share capital of the Company by an amount of sixteen million five hundred thousand United States Dollars (USD 16,500,000) by the cancellation of 11,000,000 (eleven million) shares with a nominal value of one United States Dollar and fifty cents (USD 1.50) each held in treasury by the Company; reduction of the share capital account of the Company by an amount equal to the reduction of the share capital; consequential amendment of the article 5.1 of the articles of association of the Company.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-19 |
股东大会：
将于2021-04-21召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31, 2020, 2019, and 2018.
2.Approval of the Company’s annual accounts as of December 31, 2020.
3.Allocation of results for the year ended December 31, 2020.
4.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31, 2020.
5.Approval of compensation of members of the Board of Directors for year 2020.
6.Appointment of PricewaterhouseCoopers Société Coopérative, reviseur d’entreprises agree as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31, 2021.
7.Election of the following members of the Board of Directors: (i) Mr. Guillaume van der Linden, Mr. Ivo Sarjanovic and Mr. Mark Schachter, for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2024.
8.Approval of compensation of members of the Board of Directors for year 2021.
9.Renewal of the authorization granted to the Company, and/or any wholly-owned subsidiary (and/or any person acting on their behalf), to purchase, acquire, receive and hold shares in the Company.
|
| 2020-04-01 |
股东大会：
将于2020-04-15召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31 2019, 2018, and 2017.
2.Approval of the Company’s annual accounts as of December 31 2019.
3.Allocation of results for the year ended December 31 2019.
4.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31 2019.
5.Approval of compensation of members of the Board of Directors for year 2019.
6.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé appointed as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31 2020.
7.Election of Mr. Plínio Musetti, Mr. Daniel González and Mr. Mariano Bosch as members of the Board of Directors for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2023.
8.Approval of compensation of members of the Board of Directors for year 2020.
|
| 2019-03-26 |
股东大会：
将于2019-04-17召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31 2018, 2017 and 2016.
2.Approval of the Company’s annual accounts as of December 31 2018.
3.Allocation of results for the year ended December 31 2018.
4.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31 2018.
5.Reduction of the number of members of the Board of Directors from eleven (11) to nine (9) directors.
6.Approval of compensation of members of the Board of Directors for year 2018.
7.Appointment of PricewaterhouseCoopers Societe Cooperative, reviseur d’entreprises agree as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31 2019.
8.Election of Ms. Alejandra Smith, Mr. Andres Velasco Branes and Mr. Alan Leland Boyce as members of the Board of Directors for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2022.
|
| 2018-03-26 |
股东大会：
将于2018-04-18召开股东大会
会议内容 ▼▲
- 1.Approval of the Consolidated Financial Statements as of and for the years ended December 31 2017, 2016 and 2015.
2.Approval of the Company’s annual accounts as of December 31 2017.
3.Allocation of results for the year ended December 31 2017.
4.Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31 2017.
5.Approval of compensation of members of the Board of Directors for year 2017.
6.Approval of compensation of members of the Board of Directors for year 2018.
7.Appointment of PricewaterhouseCoopers Société Coopérative, réviseur d’entreprises agréé as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31 2018.
8.Election of the following members of the Board of Directors: (i) Mr. Ivo Andrés Sarjanovic, Mr. Guillaume van der Linden, Mr. Mark Schachter and Mr. Marcelo Vieira for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2021; and (ii) Mr. Walter Marcelo Sanchez for a term of one (1) year, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2019.
|
| 2016-03-24 |
股东大会：
将于2016-04-20召开股东大会
会议内容 ▼▲
- A. Agenda for the Annual General Meeting of Shareholders
1. Approval of the Consolidated Financial Statements as of and for the years ended December 31, 2015, 2014, and 2013.
2. Approval of the Company’s annual accounts as of December 31, 2015.
3. Allocation of results for the year ended December 31, 2015.
4. Vote on discharge (quitus) of the members of the Board of Directors for the proper exercise of their mandate during the year ended December 31, 2015.
5. Approval of compensation of members of the Board of Directors for year 2015.
6. Approval of compensation of members of the Board of Directors for year 2016.
7. Appointment of PricewaterhouseCoopers Société Cooperative, réviseur d’entreprises agree as auditor of the Company for a period ending at the general meeting approving the annual accounts for the year ending December 31, 2016.
8. Election of the following members of the Board of Directors: (i) Mr. Alan Leland Boyce and Mr. Andres Velasco Branes for a term of three (3) years each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2019; and (ii) Mr. Marcelo Vieira and Mr. Walter Marcelo Sanchez for a term of one (1) year each, ending the date of the Annual General Meeting of Shareholders of the Company to be held in year 2017.
B. Agenda for the Extraordinary General Meeting of Shareholders
1. Renewal of the authorized un-issued share capital of the Company of three billion US Dollars (USD3,000,000,000) consisting in two billion (2,000,000,000) shares, each with a nominal value of one US Dollars and fifty cents (USD1.5).
2. Renewal of the authorization granted to the Company, and/or any wholly-owned subsidiary (and/or any person acting on their behalf), to purchase, acquire, receive or hold shares in the Company.
3. Approval of consequential amendment of article 5.1.1 of the articles of association of the Company.
|